Kt/V

Last updated

In medicine, Kt/V is a number used to quantify hemodialysis and peritoneal dialysis treatment adequacy.

Contents

In the context of hemodialysis, Kt/V is a pseudo-dimensionless number; it is dependent on the pre- and post-dialysis concentration (see below). It is not the product of K and t divided by V, as would be the case in a true dimensionless number. [1] In peritoneal dialysis, it isn't dimensionless at all.

It was developed by Frank Gotch and John Sargent as a way for measuring the dose of dialysis when they analyzed the data from the National Cooperative Dialysis Study. [2] In hemodialysis the US National Kidney Foundation Kt/V target is ≥ 1.3, so that one can be sure that the delivered dose is at least 1.2. [3] In peritoneal dialysis the target is ≥ 1.7/week. [3]

Despite the name, Kt/V is quite different from standardized Kt/V.

Rationale for Kt/V as a marker of dialysis adequacy

K (clearance) multiplied by t (time) is a volume (since mL/min × min = mL, or L/h × h = L), and (K × t) can be thought of as the mL or L of fluid (blood in this case) cleared of urea (or any other solute) during the course of a single treatment. V also is a volume, expressed in mL or L. So the ratio of K × t / V is a so-called "dimensionless ratio" and can be thought of as a multiple of the volume of plasma cleared of urea divided by the distribution volume of urea. When Kt/V = 1.0, a volume of blood equal to the distribution volume of urea has been completely cleared of urea.

The relationship between Kt/V and the concentration of urea C at the end of dialysis can be derived from the first-order differential equation that describes exponential decay and models the clearance of any substance from the body where the concentration of that substance decreases in an exponential fashion:

where

From the above definitions it follows that is the first derivative of concentration with respect to time, i.e. the change in concentration with time.

This equation is separable and can be integrated (assuming K and V are constant) as follows:

After integration,

where

If one takes the antilog of equation 2b the result is:

where

By integer exponentiation this can be written as:

where

The above equation can also be written as [2]

Normally we measure postdialysis serum urea nitrogen concentration C and compare this with the initial or predialysis level C0. The session length or time is t and this is measured by the clock. The dialyzer clearance K is usually estimated, based on the urea transfer ability of the dialyzer (a function of its size and membrane permeability), the blood flow rate, and the dialysate flow rate. [4] In some dialysis machines, the urea clearance during dialysis is estimated by testing the ability of the dialyzer to remove a small salt load that is added to the dialysate during dialysis.

Relation to URR

The URR or Urea reduction ratio is simply the fractional reduction of urea during dialysis. So by definition, URR = 1 − C/C0. So 1−URR = C/C0. So by algebra, substituting into equation ( 4 ) above, since ln C/C0 = − ln C0/C, we get:

Sample calculation

Patient has a mass of 70 kg (154 lb) and gets a hemodialysis treatment that lasts 4 hours where the urea clearance is 215 mL/min.

Therefore:

Kt/V = 1.23

This means that if you dialyze a patient to a Kt/V of 1.23, and measure the postdialysis and predialysis urea nitrogen levels in the blood, then calculate the URR, then −ln(1−URR) should be about 1.23.

The math does not quite work out, and more complicated relationships have been worked-out to account for the fluid removal (ultrafiltration) during dialysis as well as urea generation (see urea reduction ratio). Nevertheless, the URR and Kt/V are so closely related mathematically, that their predictive power has been shown to be no different in terms of prediction of patient outcomes in observational studies.

Post-dialysis rebound

The above analysis assumes that urea is removed from a single compartment during dialysis. In fact, this Kt/V is usually called the "single-pool" Kt/V. Due to the multiple compartments in the human body, a significant concentration rebound occurs following hemodialysis. Usually rebound lowers the Kt/V by about 15%. The amount of rebound depends on the rate of dialysis (K) in relation to the size of the patient (V). Equations have been devised to predict the amount of rebound based on the ratio of K/V, but usually this is not necessary in clinical practice. One can use such equations to calculate an "equilibrated Kt/V" or a "double-pool Kt/V", and some think that this should be used as a measure of dialysis adequacy, but this is not widely done in the United States, and the KDOQI guidelines (see below) recommend using the regular single pool Kt/V for simplicity.

Peritoneal dialysis

Kt/V (in the context of peritoneal dialysis) was developed by Michael J. Lysaght in a series of articles on peritoneal dialysis. [5] [6]

The steady-state solution of a simplified mass transfer equation that is used to describe the mass exchange over a semi-permeable membrane and models peritoneal dialysis is

where

This can also be written as:

The mass generation (of urea), in steady state, can be expressed as the mass (of urea) in the effluent per time:

where

Lysaght, motivated by equations 6b and 6c , defined the value KD:

Lysaght uses "ml/min" for the clearance. In order to convert the above clearance (which is in m3/s) to ml/min one has to multiply by 60 × 1000 × 1000.

Once KD is defined the following equation is used to calculate Kt/V:

where

The 7/3 is used to adjust the Kt/V value so it can be compared to the Kt/V for hemodialysis, which is typically done thrice weekly in the USA.

Weekly Kt/V

To calculate the weekly Kt/V (for peritoneal dialysis) KD has to be in litres/day. Weekly Kt/V is defined by the following equation:

Sample calculation

Assume:

Then by equation 6d , KD is: 1.3334×10−07 m3/s or 8.00 mL/min or 11.52 L/d.

Kt/V and the weekly Kt/V by equations 7a and 7b respectively are thus: 0.45978 and 1.9863.

A simplified analysis of Kt/V in PD

On a practical level, in peritoneal dialysis the calculation of Kt/V is often relatively easy because the fluid drained is usually close to 100% saturated with urea,[ citation needed ] i.e. the dialysate has equilibriated with the body. Therefore, the daily amount of plasma cleared is simply the drain volume divided by an estimate of the patient's volume of distribution.

As an example, if someone is infusing four 2 liter exchanges a day, and drains out a total of 9 liters per day, then they drain 9 × 7 = 63 liters per week. If the patient has an estimated total body water volume V of about 35 liters, then the weekly Kt/V would be 63/35, or about 1.8.

The above calculation is limited by the fact that the serum concentration of urea is changing during dialysis. So ideally this should not be used as it has not taken in account the urea level in dialysate or serum...so it cannot be labelled as urea clearance In automated PD this change cannot be ignored; thus, blood samples are usually measured at some time point in the day and assumed to be representative of an average value. The clearance is then calculated using this measurement.

Reason for adoption

Kt/V has been widely adopted because it was correlated with survival. Before Kt/V nephrologists measured the serum urea concentration (specifically the time-averaged concentration of urea (TAC of urea)), which was found not to be correlated with survival (due to its strong dependence on protein intake) and thus deemed an unreliable marker of dialysis adequacy.

Criticisms/disadvantages of Kt/V

Importance of total weekly dialysis time and frequency

Kt/V has been criticized because quite high levels can be achieved, particularly in smaller patients, during relatively short dialysis sessions. This is especially true for small people, where "adequate" levels of Kt/V often can be achieved over 2 to 2.5 hours. One important part of dialysis adequacy has to do with adequate removal of salt and water, and also of solutes other than urea, especially larger molecular weight substances and phosphorus. Phosphorus and similar molecular weights remain elusive to filtration of any degree. A number of studies suggest that a longer amount of time on dialysis, or more frequent dialysis sessions, lead to better results. There have been various alternative methods of measuring dialysis adequacy, most of which have proposed some number based on Kt/V and number of dialysis sessions per week, e.g., the standardized Kt/V, or simply number of dialysis sessions per week squared multiplied by the hours on dialysis per session; e.g. the hemodialysis product by Scribner and Oreopoulos [9] It is not practical to give long dialysis sessions (greater than 4.5 hours) thrice a week in a dialysis center during the day. Longer sessions can be practically delivered if dialysis is done at home. Most experience has been gained with such long dialysis sessions given at night. Some centers are offering every-other-night or thrice a week nocturnal dialysis. The benefits of giving more frequent dialysis sessions is also an area of active study, and new easy-to-use machines are permitting easier use of home dialysis, where 2–3+ hour sessions can be given 4–7 days per week.

Kt/V minimums and targets for hemodialysis

One question in terms of Kt/V is, how much is enough? The answer has been based on observational studies, and the NIH-funded HEMO trial done in the United States, and also, on kinetic analysis. For a US perspective, see the KDOQI clinical practice guidelines [10] and for a United Kingdom perspective see: U.K. Renal Association clinical practice guidelines [11] According to the US guidelines, for thrice a week dialysis a Kt/V (without rebound) should be 1.2 at a minimum with a target value of 1.4 (15% above the minimum values). However, there is suggestive evidence that larger amounts may need to be given to women, smaller patients, malnourished patients, and patients with clinical problems. The recommended minimum Kt/V value changes depending on how many sessions per week are given, and is reduced for patients who have a substantial degree of residual renal function.

Kt/V minimums and targets for peritoneal dialysis

For a US perspective, see: [12] For the United States, the minimum weekly Kt/V target used to be 2.0. This was lowered to 1.7 in view of the results of a large randomized trial done in Mexico, the ADEMEX trial, [13] and also from reanalysis of previous observational study results from the perspective of residual kidney function.

For a United Kingdom perspective see: [14] This is still in draft form.

Related Research Articles

<span class="mw-page-title-main">Kidney dialysis</span> Removal of nitrogenous waste and toxins from the body in place of or to augment the kidney

Kidney dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy. The first successful dialysis was performed in 1943.

<span class="mw-page-title-main">Creatinine</span> Breakdown product of creatine phosphate

Creatinine is a breakdown product of creatine phosphate from muscle and protein metabolism. It is released at a constant rate by the body.

<span class="mw-page-title-main">Uremia</span> Excess urea in the blood due to kidney dysfunction

Uremia is the term for high levels of urea in the blood. Urea is one of the primary components of urine. It can be defined as an excess in the blood of amino acid and protein metabolism end products, such as urea and creatinine, which would be normally excreted in the urine. Uremic syndrome can be defined as the terminal clinical manifestation of kidney failure. It is the signs, symptoms and results from laboratory tests which result from inadequate excretory, regulatory, and endocrine function of the kidneys. Both uremia and uremic syndrome have been used interchangeably to denote a very high plasma urea concentration that is the result of renal failure. The former denotation will be used for the rest of the article.

<span class="mw-page-title-main">Glomerular filtration rate</span> Renal function test

Renal functions include maintaining an acid–base balance; regulating fluid balance; regulating sodium, potassium, and other electrolytes; clearing toxins; absorption of glucose, amino acids, and other small molecules; regulation of blood pressure; production of various hormones, such as erythropoietin; and activation of vitamin D.

<span class="mw-page-title-main">Hemodialysis</span> Medical procedure for purifying blood

Hemodialysis, also spelled haemodialysis, or simply dialysis, is a process of filtering the blood of a person whose kidneys are not working normally. This type of dialysis achieves the extracorporeal removal of waste products such as creatinine and urea and free water from the blood when the kidneys are in a state of kidney failure. Hemodialysis is one of three renal replacement therapies. An alternative method for extracorporeal separation of blood components such as plasma or cells is apheresis.

<span class="mw-page-title-main">Assessment of kidney function</span> Ways of assessing the function of the kidneys

Assessment of kidney function occurs in different ways, using the presence of symptoms and signs, as well as measurements using urine tests, blood tests, and medical imaging.

<span class="mw-page-title-main">Peritoneal dialysis</span> Blood purification procedure using the abdominal peritoneum

Peritoneal dialysis (PD) is a type of dialysis that uses the peritoneum in a person's abdomen as the membrane through which fluid and dissolved substances are exchanged with the blood. It is used to remove excess fluid, correct electrolyte problems, and remove toxins in those with kidney failure. Peritoneal dialysis has better outcomes than hemodialysis during the first couple of years. Other benefits include greater flexibility and better tolerability in those with significant heart disease.

<span class="mw-page-title-main">Home hemodialysis</span>

Home hemodialysis (HHD) is the provision of hemodialysis to purify the blood of a person whose kidneys are not working normally, in their own home. One advantage to doing dialysis at home is that it can be done more frequently and slowly, which reduces the "washed out" feeling and other symptoms caused by rapid ultrafiltration, and it can often be done at night, while the person is sleeping.

Hemodialysis product (HDP) - is a number used to quantify hemodialysis and peritoneal dialysis treatment adequacy.

<span class="mw-page-title-main">Artificial kidney</span> Kidney other than the natural organ

Artificial kidney is often a synonym for hemodialyzer, but may also refer to the other renal replacement therapies that are in use and/or in development. This article deals mainly with bio-artificial kidneys featuring cells that are grown from renal cell lines/renal tissue.

In pharmacology, clearance is a pharmacokinetic parameter representing the efficiency of drug elimination. This is the rate of elimination of a substance divided by its concentration. The parameter also indicates the theoretical volume of plasma from which a substance would be completely removed per unit time. Usually, clearance is measured in L/h or mL/min. The quantity reflects the rate of drug elimination divided by plasma concentration. Excretion, on the other hand, is a measurement of the amount of a substance removed from the body per unit time. While clearance and excretion of a substance are related, they are not the same thing. The concept of clearance was described by Thomas Addis, a graduate of the University of Edinburgh Medical School.

The urea reduction ratio (URR) is a dimensionless number used to quantify dialysis treatment adequacy.

<span class="mw-page-title-main">Hemofiltration</span> Medical procedure

Hemofiltration, also haemofiltration, is a renal replacement therapy which is used in the intensive care setting. It is usually used to treat acute kidney injury (AKI), but may be of benefit in multiple organ dysfunction syndrome or sepsis. During hemofiltration, a patient's blood is passed through a set of tubing via a machine to a semipermeable membrane where waste products and water are removed by convection. Replacement fluid is added and the blood is returned to the patient.

Standardized Kt/V, also std Kt/V, is a way of measuring (renal) dialysis adequacy. It was developed by Frank Gotch and is used in the United States to measure dialysis. Despite the name, it is quite different from Kt/V. In theory, both peritoneal dialysis and hemodialysis can be quantified with std Kt/V.

<span class="mw-page-title-main">Frank Gotch (physician)</span> American physician

Frank A. Gotch was an American physician known for his work in renal dialysis adequacy, specifically the development of Kt/V and standardized Kt/V. He was an Associate Professor of Medicine at the University of California, San Francisco.

In nephrology, dialysis adequacy is the measurement of renal dialysis for the purpose of determining dialysis treatment regime and to better understand the pathophysiology of renal dialysis. It is an area of considerable controversy in nephrology.

<span class="mw-page-title-main">Dialysis disequilibrium syndrome</span> Complication of dialysis

Dialysis disequilibrium syndrome (DDS) is the collection of neurological signs and symptoms, attributed to cerebral edema, during or following shortly after intermittent hemodialysis or CRRT.

Nathan W. Levin is an American physician and founder of the Renal Research Institute, LLC., a research institute dedicated to improving the outcomes of patients with kidney disease, particularly those requiring dialysis. Levin is one of the most prominent and renowned figures in clinical nephrology as well as nephrology research. He has authored multiple book chapters and over 350 peer-reviewed publications, including articles in leading journals such as Nature, the New England Journal of Medicine, and The Lancet.

Aluminium toxicity in people on dialysis is a problem for people on haemodialysis. Aluminium is often found in unfiltered water used to prepare dialysate. The dialysis process does not efficiently remove excess aluminium from the body, so it may build up over time. Aluminium is a potentially toxic metal, and aluminium poisoning may lead to mainly three disorders: aluminium-induced bone disease, microcytic anemia and neurological dysfunction (encephalopathy). Such conditions are more prominently observed in people with chronic kidney failure and especially in people on haemodialysis.

Qian Jiaqi, also romanized as Jia-Qi Qian, was a Chinese nephrologist and professor at Renji Hospital of Shanghai Jiao Tong University School of Medicine. He was the first clinical physician to perform hemodialysis and peritoneal dialysis in China, and established a Kt/V value of at least 1.7 as the target for peritoneal dialysis.

References

  1. Bonert, M.; Saville, BA. (2010). "A non-dimensional analysis of hemodialysis". Open Biomed Eng J. 4: 138–55. doi: 10.2174/1874120701004010138 . PMC   3111706 . PMID   21673980.
  2. 1 2 Gotch FA, Sargent JA (September 1985). "A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)". Kidney Int. 28 (3): 526–34. doi: 10.1038/ki.1985.160 . PMID   3934452.
  3. 1 2 "Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation". Am J Kidney Dis. 35 (6 Suppl 2): S1–140. 2000. doi:10.1053/ajkd.2000.v35.aajkd03517. PMID   10895784. Archived from the original on 2006-09-03.
  4. Babb AL, Popovich RP, Christopher TG, Scribner BH (1971). "The genesis of the square meter-hour hypothesis". Trans Am Soc Artif Intern Organs. 17: 81–91. PMID   5158139.
  5. Lysaght MJ, Farrell PC (1989). "Membrane Phenomena and mass transfer kinetics in peritoneal dialysis". Journal of Membrane Science. 44 (1): 5–33. doi:10.1016/S0376-7388(00)82339-X.
  6. Lysaght MJ, Pollock CA, Hallet MD, Ibels LS, Farrell PC (1989). "The relevance of urea kinetic modeling to CAPD". ASAIO Trans. 35 (4): 784–90. PMID   2611047.
  7. Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP, Rosevear JW (January 1972). "Effects of urea loading in patients with far-advanced renal failure". Mayo Clinic Proceedings. 47 (1): 21–9. PMID   5008253.
  8. Daugirdas JT et al. Surface-area-normalized (SAN) adjustment to Kt/V and weekly standard Kt/V. J Am Soc Nephrol (abstract) 2006. and Appendix A. Handbook of Dialysis, 4th Edition. Daugirdas JT, Blake PB, Ing TS, editors. Lippincott Williams and Wilkins, Philadelphia, 2007.
  9. Scribner BH, Oreopoulos DG (January 2002). "The Hemodialysis Product (HDP): A Better Index of Dialysis Adequacy than Kt/V" (PDF). Dialysis & Transplantation. 31 (1): 13–5. Archived from the original (mirrored PDF) on 2016-03-03. Retrieved 2007-02-07.
  10. KDOQI Hemodialysis Adequacy Archived 2007-02-11 at the Wayback Machine Update 2006.
  11. U.K. Renal Association Clinical Practice Guidelines, 2006 Update. Archived 2007-02-09 at the Wayback Machine
  12. KDOQI Peritoneal Adequacy Archived 2007-07-11 at the Wayback Machine Update 2006.
  13. Paniagua R, Amato D, Vonesh E, et al. (May 2002). "Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial". J Am Soc Nephrol. 13 (5): 1307–20. doi: 10.1681/ASN.V1351307 . PMID   11961019.
  14. U.K. Renal Association Clinical Practice Guidelines, Peritoneal Dialysis. Archived 2007-02-10 at the Wayback Machine 2006 Update.

Hemodialysis

Peritoneal dialysis

Calculators